Results 11 to 20 of about 1,053 (167)

Off-Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives. [PDF]

Exp Dermatol
JAK inhibitors are used to treat various inflammatory skin diseases. However, systemic formulations are associated with an increased risk of major adverse events.
Spadafora M, Morsia S, Di Lernia VG, Kaleci S, Pellacani G, Longo C.   +5 more
europepmc   +4 more sources

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 2, Scleromyxoedema and scleroedema [PDF]

Journal of the European Academy of Dermatology and Venereology, Volume 38, Issue 7, Page 1281-1299, July 2024.
The term 'sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly manifest in different clinical subtypes according to cutaneous and extracutaneous involvement ...
Knobler, Robert, Sunderkötter, Cord
core   +8 more sources

Combination intravenous immunoglobulin, oral prednisone, and methotrexate for managing scleromyxedema: case report and literature discussion [PDF]

Dermatology Reports, 2023
Scleromyxedema (SMX), the generalized and sclerodermic form of lichen myxedematous (LM), is a chronic mucinosis characterized by cutaneous manifestation and several systemic comorbidities.
Gaia Fasano, Giancarlo Valenti, Domenico D'Amico, Mario Valenti   +3 more
doaj   +2 more sources

Scleromyxedema: An atypical case

Indian Journal of Dermatology, 2015
Scleromyxedema is a rare, chronic and persistent idiopathic disorder characterized by a generalized papular eruption due to dermal mucin deposition with an increase in dermal collagen. Patients usually have associated paraproteinemia.
Emy Thomas, Anisha George, Divya Deodhar, Mary John   +3 more
doaj   +3 more sources

Unusual Cutaneous Manifestations in a Patient with a History of Hepatitis B: A Case of Scleromyxedema and Literature Review [PDF]

Clinical, Cosmetic and Investigational Dermatology
Aili Gao, Xin Tian, Dexiu Lang, Yue Chen Department of Dermatology, Guangzhou Dermatology Hospital, Guangzhou, Guangdong, People’s Republic of ChinaCorrespondence: Yue Chen, Department of Dermatology, Guangzhou Dermatology Hospital, Guangzhou, People’s ...
Gao A, Tian X, Lang D, Chen Y
doaj   +2 more sources

Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin [PDF]

JAAD Case Reports, 2023
Donglin Zhang, BA, Kimberly Sable, MD, Allison Miller, MD, Molly Hinshaw, MD, Timothy Schmidt, MD, Bridget E. Shields, MD   +5 more
doaj   +2 more sources

Hyalase in Dermatology: Applications Beyond Filler Management. [PDF]

J Cosmet Dermatol
ABSTRACT Background Hyaluronic acid (HA) is a key extracellular matrix component in the skin. Hyaluronidase is an enzyme that breaks down HA into monosaccharides. The FDA has approved this enzyme for hypodermoclysis, drug absorption enhancement, and subcutaneous urography.
Hasanzadeh S, Farokh P, Hosseini GS, Abbasian M, Etesami I, Zaresharifi S, Dadkhahfar S.   +6 more
europepmc   +2 more sources

Sclerosing diseases of the skin. [PDF]

J Dtsch Dermatol Ges
Summary Sclerosing skin diseases comprise a group of distinct dermatological conditions characterized by fibrotic changes that may severely impair patients’ quality of life. These conditions often present with cutaneous manifestations and, in some cases, may extend to extracutaneous tissues, potentially resulting in significant morbidity and mortality.
Kalantari Y, Meier K, Ghoreschi K, Kinberger M, Solimani F.   +4 more
europepmc   +2 more sources

Discrete papular lichen myxedematosus successfully treated with isotretinoin [PDF]

JAAD Case Reports
Alexa Figueroa Baiges, BS, Nina Punyamurthy, MD, Alexander M. Maley, MD   +2 more
doaj   +2 more sources

Scleromyxedema [PDF]

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2020
SummaryScleromyxedema is a rare, cutaneous deposition disorder from the group of mucinoses, which can affect multiple organs and is virtually always associated with a monoclonal gammopathy. Cutaneous manifestations are usually generalized, 2 to 3 mm sized, dome‐shaped or flat‐topped, waxy, slightly red to skin‐colored papules and sclerodermoid ...
Jochen H O, Hoffmann, Alexander H, Enk
openaire   +4 more sources